Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from MedX Health ( (TSE:MDX) ).
MedX Health Corp. has appointed Dr. Symon D. Cotton as Strategic Advisor to enhance its AI and product development efforts. Dr. Cotton, a key figure in the development of SIAscopy®, brings extensive expertise in medical technology innovation, particularly in AI-driven analytics for medical imaging. His appointment is expected to bolster MedX’s strategic roadmap, enhancing diagnostic accuracy and scalability in teledermatology, and further solidifying its leadership in the industry.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. The company’s proprietary SIAscopy® technology, integrated into the DermSecure® platform, allows for pain-free, accurate imaging of skin lesions, facilitating rapid dermatologist review. MedX’s products are approved for use in 38 territories worldwide, including Canada, the U.S., Australia, New Zealand, the UK, the EU, and Turkey.
Average Trading Volume: 144,533
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$19.62M
For an in-depth examination of MDX stock, go to TipRanks’ Overview page.